A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
Clinical trial NCT05827926 · COMPLETED
Trial details
- NCT number
- NCT05827926
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2024-12-03
- Enrollment
- 1758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.